SPRED2 and hyperaldosteronism: Recently, Ullrich et al. showed that SPRED2 (65M) is a negative regulator of the hypothalamic-pituitary-adrenal axis and contributes to the modulation of hyperaldosteronism and homeostatic imbalances [29].